BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 27532149)

  • 41. Bulky mesonephric adenocarcinoma of the uterine cervix treated with neoadjuvant chemotherapy and radical surgery: report of the first case.
    Ditto A; Martinelli F; Bogani G; Gasparri ML; Donato VD; Paolini B; Carcangiu ML; Lorusso D; Raspagliesi F
    Tumori; 2016 Nov; 102(Suppl. 2):. PubMed ID: 26166228
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeted Genomic Profiling of Female Adnexal Tumors of Probable Wolffian Origin (FATWO).
    Mirkovic J; Dong F; Sholl LM; Garcia E; Lindeman N; MacConaill L; Crum CP; Nucci MR; McCluggage WG; Howitt BE
    Int J Gynecol Pathol; 2019 Nov; 38(6):543-551. PubMed ID: 30134342
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cervical Carcinoma With Divergent Neuroendocrine and Gastrointestinal Differentiation.
    Varma KR; Dabbs DJ
    Int J Gynecol Pathol; 2018 Sep; 37(5):488-491. PubMed ID: 28863067
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative genomics of high grade neuroendocrine carcinoma of the cervix.
    Hillman RT; Cardnell R; Fujimoto J; Lee WC; Zhang J; Byers LA; Ramalingam P; Leitao M; Swisher E; Futreal PA; Frumovitz M
    PLoS One; 2020; 15(6):e0234505. PubMed ID: 32544169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular abnormalities associated with endocrine tumors of the uterine cervix.
    Wistuba II; Thomas B; Behrens C; Onuki N; Lindberg G; Albores-Saavedra J; Gazdar AF
    Gynecol Oncol; 1999 Jan; 72(1):3-9. PubMed ID: 9889022
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Squamous cell carcinoma in situ involving mesonephric remnants of the uterine cervix.
    Zámecník M
    Cesk Patol; 2004 Jul; 40(3):109-11. PubMed ID: 15493419
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunopathological study of mesonephric lesions of cervix uteri and vagina.
    Kondi-Pafitis A; Kairi E; Kontogianni KI; Dimopoulou C; Sikiotis K; Smyrniotis V
    Eur J Gynaecol Oncol; 2003; 24(2):154-6. PubMed ID: 12701967
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mesonephric remnant hyperplasia of the cervix: a clinicopathologic analysis of 14 cases.
    Jones MA; Andrews J; Tarraza HM
    Gynecol Oncol; 1993 Apr; 49(1):41-7. PubMed ID: 8482559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mesonephric rest hyperplasia. A potential diagnostic pitfall.
    Amin-Hanjani S; Paulson J; Henien S; Hanjani P
    Arch Pathol Lab Med; 1991 Oct; 115(10):1059-61. PubMed ID: 1898238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clear cell carcinoma of the uterine endocervix with an in situ component.
    Hasumi K; Ehrmann RL
    Cancer; 1978 Nov; 42(5):2435-8. PubMed ID: 719620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urethral obstruction due to lobular mesonephric hyperplasia of the vagina--a case report.
    Handoo A; Kini H; Pai R; Prabhu GG
    Indian J Pathol Microbiol; 2005 Jan; 48(1):20-1. PubMed ID: 16758778
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carcinosarcoma of the uterine cervix: a rare pathological finding originating from mesonephric remnants.
    Ribeiro B; Silva R; Dias R; Patrício V
    BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30936330
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mesonephric adenocarcinomas of the uterine cervix: a study of 11 cases with immunohistochemical findings.
    Silver SA; Devouassoux-Shisheboran M; Mezzetti TP; Tavassoli FA
    Am J Surg Pathol; 2001 Mar; 25(3):379-87. PubMed ID: 11224609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PAX8 expression in uterine adenocarcinomas and mesonephric proliferations.
    Yemelyanova A; Gown AM; Wu LS; Holmes BJ; Ronnett BM; Vang R
    Int J Gynecol Pathol; 2014 Sep; 33(5):492-9. PubMed ID: 25083965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mixed endocervical adenocarcinoma and high-grade neuroendocrine carcinoma of the cervix with ovarian metastasis of the former component: a report of 2 cases.
    Ramalingam P; Malpica A; Deavers MT
    Int J Gynecol Pathol; 2012 Sep; 31(5):490-6. PubMed ID: 22833092
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multiomics sequencing and immune microenvironment characteristics define three subtypes of small cell neuroendocrine carcinoma of the cervix.
    Pan B; Yan S; Yuan L; Xiang H; Ju M; Xu S; Jia W; Li J; Zhao Q; Zheng M
    J Pathol; 2024 Jul; 263(3):372-385. PubMed ID: 38721894
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coexisting squamous cell carcinoma and high-grade neuroendocrine carcinoma, small cell type: a rare collision in cervix.
    Kaushal S; Mathur SR; Kumar S
    BMJ Case Rep; 2018 May; 2018():. PubMed ID: 29778998
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A rare case of primary ovarian mesonephric adenocarcinoma and a review of the literature.
    Canbey C; Ceylan EC; Demir I; Solak HT; Erel E; Aybek OY; Senol T
    Ann Ital Chir; 2022 Mar; 11():. PubMed ID: 35348127
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Carcinoma of the Uterine Cervix Involving the Genitourinary Tract: A Potential Diagnostic Dilemma.
    Schwartz LE; Khani F; Bishop JA; Vang R; Epstein JI
    Am J Surg Pathol; 2016 Jan; 40(1):27-35. PubMed ID: 26426382
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinicopathological characteristics and molecular abnormalities of primary grade 2 neuroendocrine tumors of the cervix.
    Zhu R; Wu H; Chen B; Pang J; Huo Z
    Diagn Pathol; 2019 Jun; 14(1):64. PubMed ID: 31228945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.